25.05 Johnson&Johnson FDA 10 2017 .
Johnson&Johnson, 2017 . Janssen FDA 10 25 , FirstWord Pharma.
C simeprevir, FDA. 2013 .
, Janssen ibrutinib, Pharmacyclics, daratumumab, Genmab.
GlaxoSmithKline sirukumab, 2012 .
guselkumab Invega (paliperidone), , , .
Johnson&Johnson, 2012 . , 2009 ., 17% 7% .
- . , 3 . 2017 . .
. 2017 . 6 .